<DOC>
	<DOC>NCT01897948</DOC>
	<brief_summary>This clinical trial will measure Docosahexaenic Acid (DHA) levels in the blood and evaluate the relation to cognitive outcomes.</brief_summary>
	<brief_title>The Effects of Feeding Different Levels of Docosahexaenoic Acid to Pre-School Children</brief_title>
	<detailed_description />
	<criteria>Child is 3 years of age ± 90 days Weight for length is within 10th to 90th percentile as plotted on WHO growth charts Parent/caregiver reports that child consumes at least 6 oz of cow milk or cow milkbased beverages on a daily basis Parent is willing to exclude sources of DHA from child's diet during the study Parent agrees not to give vitamins to child during the study English is the primary language in the home Signed Informed Consent and Protected Health Information Gestational age at birth ≤ 36 weeks History of neuro/psychiatric conditions History of underlying metabolic or chronic disease Child is ill, has used antihistamines or diagnosed with an infection at time of cognitive testing History of suspected or known cow milk protein intolerance Child's diet contains sources of supplemental DHA more than one time per week Child is from a multiple birth and the sibling(s) are living in the same household Child is enrolled in another interventional clinical research study Use of antihistamines within 12 hours of cognitive testing</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>